Close

SCLN Financial Facts

General and administrative: 7.9M
Income from operations: 10.45M
See Full Income Statement

Accrued and other current liabilities: 19.88M
Accumulated deficit: -94.18M
See Full Balance Sheet

SciClone Pharmaceuticals, Inc. (SCLN) Earnings

  |   Expand Research on SCLN
Next EPS Date N/A EPS Growth Rate N/A
Average EPS % Beat Rate +203.3% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS +2.1% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
11/9/12 Q312 $0.20$0.21 -$0.01$40.7M$44.8M Details
11/9/16 Q316 $0.24N/A N/A $40.5M$42.9M N/A Details
8/8/12 Q212 $0.19$0.17 +$0.02$40.3M$41.98M Details
3/10/16 Q415 $0.30N/A N/A $42.9M$41.1M N/A Details
3/13/12 Q411 $0.20$0.12 +$0.08$41.4M$40.39M Details
5/10/17 Q117 $0.31$0.14 +$0.17$42.9M$39.94M = Details
11/12/13 Q313 $0.18$0.15 +$0.03$35.2M$39.7M = Details
3/12/14 Q413 $0.08$0.15 -$0.07$32.7M$38.3M Details